15313-47-0

Usage

Uses

Used in Pharmaceutical Industry:
ETHYL 2-(2,4-DICHLOROANILINO)-2-OXOACETATE is used as an intermediate in the synthesis of pharmaceuticals for its ability to contribute to the development of new drugs. Its chemical properties allow it to be a part of complex organic molecules that can target specific biological pathways or conditions.
Used in Agrochemical Industry:
In the agrochemical sector, ETHYL 2-(2,4-DICHLOROANILINO)-2-OXOACETATE is used as a precursor in the production of pesticides. Its antimicrobial and antifungal properties are leveraged to create compounds that can protect crops from diseases and pests, thereby increasing agricultural yields.
Used in Chemical Research:
ETHYL 2-(2,4-DICHLOROANILINO)-2-OXOACETATE is also utilized in chemical research for the exploration of new organic compounds and their potential applications. Its unique structure and reactivity make it a subject of interest for scientists working on innovative chemical processes and products.

InChI:InChI=1/C10H9Cl2NO3/c1-2-16-10(15)9(14)13-8-4-3-6(11)5-7(8)12/h3-5H,2H2,1H3,(H,13,14)

Upstream product

• 554-00-7 2,4-Dichloroaniline 
• 95-92-1 oxalic acid diethyl ester 
• 4755-77-5 Ethyl oxalyl chloride 

Downstream Products

• 53117-31-0 N-(2,4-Dichlor-phenyl)-oxaminsaeure-hydrazid 
• 93810-54-9 N'-(4-Diaethylamino-1-methyl-butyl)-N-(2,4-dichlor-phenyl)-oxamid 
• 1266620-33-0 C₁₇H₂₃Cl₂N₃O₂ 
• 117077-89-1 ethyl(2,4-dichlorophenylamino)hydroxyiminoacetate 
• 93310-17-9 N'-(2-Diaethylamino-aethyl)-N-(2,4-dichlor-phenyl)-oxamid 

Relevant academic research and scientific papers

Triphenylphosphine-catalyzed simple synthesis of dimethyl 1-aryl-4-ethoxy-5-oxo-4,5-dihydro-1H-pyrrole-2,3-dicarboxylates

Ethyl 2-arylamino-2-oxo-acetates undergo a complex reaction with dimethyl acetylenedicarboxylate in the presence of triphenylphosphine to produce dimethyl 1-aryl-4-ethoxy-5-oxo-4,5-dihydro-1H-pyrrole-2,3-dicarboxylates in good yields. Dynamic NMR study of

Design, synthesis and biological evaluation of small molecule inhibitors of CD4-gp120 binding based on virtual screening

The low-molecular-weight compound JRC-II-191 inhibits infection of HIV-1 by blocking the binding of the HIV-1 envelope glycoprotein gp120 to the CD4 receptor and is therefore an important lead in the development of a potent viral entry inhibitor. Reported here is the use of two orthogonal screening methods, gold docking and ROCS shape-based similarity searching, to identify amine-building blocks that, when conjugated to the core scaffold, yield novel analogs that maintain similar affinity for gp120. Use of this computational approach to expand SAR produced analogs of equal inhibitory activity but with diverse capacity to enhance viral infection. The novel analogs provide additional lead scaffolds for the development of HIV-1 entry inhibitors that employ protein-ligand interactions in the vestibule of gp120 Phe 43 cavity.

SUBSTITUTED TRIAZOLECARBOXAMIDES

Substituted triazolecarboxamides A b s t r a c t The invention relates to substituted triazolecarboxamides of the formula (I) in which R1, R2, R3 and R4 are as defined in the description, to their use as crop treatment agents, in particular as herbicides,